Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

BTOG 2024

17–19 April 2024 | Belfast, UK

BTOG 2024

17–19 April 2024 | Belfast, UK
Challenges in timely assessment and access to care for lung cancer 2:24
Challenges in timely assessment and access to care for lung cancer
Mariana Brandao • 18 Apr 2024
Evolving definitions of resectability in stage III lung cancer 4:06
Evolving definitions of resectability in stage III lung cancer
Mariana Brandao • 18 Apr 2024
NI-HEART study results: cardiotoxicity after lung cancer radiotherapy 3:08
NI-HEART study results: cardiotoxicity after lung cancer radiotherapy
Gerard Walls • 18 Apr 2024
Addressing challenges in collecting cardiac toxicity data: NI-HEART analysis 1:14
Addressing challenges in collecting cardiac toxicity data: NI-HEART analysis
Gerard Walls • 18 Apr 2024
Exploring novel therapeutics in lung cancer: insights from BTOG 2024 1:45
Exploring novel therapeutics in lung cancer: insights from BTOG 2024
Adam Januszewski • 18 Apr 2024
Assessing vaccine delivery in lung cancer care 0:53
Assessing vaccine delivery in lung cancer care
Adam Januszewski • 18 Apr 2024
Promising role of liquid biopsies in lung cancer 0:42
Promising role of liquid biopsies in lung cancer
Adam Januszewski • 18 Apr 2024
Assessing operability in NSCLC: challenges and considerations 2:45
Assessing operability in NSCLC: challenges and considerations
Mariana Brandao • 18 Apr 2024
Targeting KRAS mutations in lung cancer 2:26
Targeting KRAS mutations in lung cancer
Thomas Newsom-Davis • 18 Apr 2024
Personalized treatment planning for lung cancer with interstitial lung disease 1:08
Personalized treatment planning for lung cancer with interstitial lung disease
Matthew Hatton • 19 Apr 2024
Exploring ILD drugs in lung cancer: research gaps and opportunities 1:00
Exploring ILD drugs in lung cancer: research gaps and opportunities
Matthew Hatton • 19 Apr 2024
Reflecting on BTOG 2024: networking and multidisciplinary collaboration 2:33
Reflecting on BTOG 2024: networking and multidisciplinary collaboration
Sanjay Popat • 19 Apr 2024
Managing lung cancer patients with ILD: the oncology perspective 1:44
Managing lung cancer patients with ILD: the oncology perspective
Matthew Hatton • 18 Apr 2024
Assessing treatment options for lung cancer with interstitial lung disease 0:45
Assessing treatment options for lung cancer with interstitial lung disease
Matthew Hatton • 18 Apr 2024
What is the optimal follow-up for lung cancer long term survivors? 7:37
What is the optimal follow-up for lung cancer long term survivors?
Robert Rintoul • 19 Apr 2024
Assessing follow-up strategies in post-surgical lung cancer: insights from a Phase III trial 1:47
Assessing follow-up strategies in post-surgical lung cancer: insights from a Phase III trial
Robert Rintoul • 19 Apr 2024
The content of VJOncology is intended for healthcare professionals